Can cannabis-derived ingredients be used in cosmetic products?

Skincare products containing cannabis are growing in popularity. Cannabis derivatives have become trendy ingredients for cosmetics manufacturers. Let’s have a brief look at the current regulatory status of this popular cosmetic ingredient in Canada. Cannabinoids come from three

The FDA needs your help!

The FDA has announced today that it seeks public comments on a proposed consumer survey about allergens in cosmetics! Cosmetics are a broad category that includes items such as fragrances, hair products, makeup, nail products, and skin care

Summer, Sun, and Sunscreens!

It’s this time of the year again: sun protection is on everyone’s lips…  including regulatory agencies! For instance, the FDA has multiplied its efforts to ensure consumers’ protection by sending warning letters to companies that mislead consumers by

Summer is here!

Sunscreens are back on store shelves and consumers debate to choose the best formula. As we all know, two categories of sunscreen, differing on their distinct mode of action, are available: Chemical sunscreen: composed of organic molecules that

Truthful product claims?

Product claims communicate the benefits of a cosmetic product to the consumers. They can be found on product packaging, labeling or any other form of advertisement including brochures, television or website. Regulatory agencies such as the FTC (Federal

The FDA is watching you!

The FDA has been extremely active last month and they are keeping a close eye on cosmetic manufacturers that make drug claims. Terms such as inflammation, oxidation, genes – anything that mention changes to the body – will be

Consumers and Governments are watching: test your products!

Manufacturers and distributors of personal care and cosmetic products are responsible for ensuring that their products and ingredients are safe. In addition, they must be able to demonstrate proofs of performance claims and they must correctly label their

FDA provides multilingual documentation

The FDA has extended its international operation model and now provides key regulatory laws and practices in multiple languages. This will also enable the industry and FDA’s foreign counterparts to better understand the agency’s laws and practices. Reference

Guidelines for Good Clinical Practice (GCP)

The ethics and scientific quality of human clinical trials is regulated by international standards set by the International Conference on Harmonization (ICH) in the form of guidelines known as Good Clinical Practice (GCP). These guidelines are accepted worldwide